ValiRx plc ( (GB:VAL) ) has issued an announcement.
ValiRx PLC, a company involved in the biotechnology sector, announced a change in the holdings of its voting rights. Stephen Wolstenhulme has acquired a total of 5.84% of the voting rights, indicating a significant stake in the company. This development is essential for stakeholders as it could impact the company’s decision-making processes and governance.
More about ValiRx plc
YTD Price Performance: -7.05%
Average Trading Volume: 7,837,998
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £2.71M
See more data about VAL stock on TipRanks’ Stock Analysis page.